VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 6, 2008) - ALDA Pharmaceuticals Corp. (TSX VENTURE:APH)(“ALDA”) announces that it has received the final results from BioScience Laboratories, Inc. for the T36® formulation (“T36®") tested against 10 different types of viruses. Of these, 5 types were killed within the minimum 30-second time required by the FDA, including Herpes Types I and II and Influenza B. The remaining 5 types, including Polio and Hepatitis A, the hardiest viruses, were killed within 1 to 3 minutes.
